Robert E. Royer

6.5k total citations · 1 hit paper
102 papers, 5.1k citations indexed

About

Robert E. Royer is a scholar working on Molecular Biology, Genetics and Cancer Research. According to data from OpenAlex, Robert E. Royer has authored 102 papers receiving a total of 5.1k indexed citations (citations by other indexed papers that have themselves been cited), including 43 papers in Molecular Biology, 33 papers in Genetics and 22 papers in Cancer Research. Recurrent topics in Robert E. Royer's work include BRCA gene mutations in cancer (32 papers), DNA Repair Mechanisms (18 papers) and Genomic variations and chromosomal abnormalities (12 papers). Robert E. Royer is often cited by papers focused on BRCA gene mutations in cancer (32 papers), DNA Repair Mechanisms (18 papers) and Genomic variations and chromosomal abnormalities (12 papers). Robert E. Royer collaborates with scholars based in United States, Canada and Brazil. Robert E. Royer's co-authors include David L. Vander Jagt, Lorraine M. Deck, Lucy A. Hunsaker, Steven A. Narod, Anirban Maitra, Chi V. Dang, Arvin M. Gouw, Ramani Dinavahi, Charles R. Cooper and Anne Le and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Journal of Clinical Oncology.

In The Last Decade

Robert E. Royer

100 papers receiving 4.9k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Inhibition of lactate dehydrogenase A induces oxidative stress and inhibits tumor progression

2010 1.2k citations Anne Le, Charles R. Cooper et al. Proceedings of the National Academy of Sciences profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Robert E. Royer United States	35	2.3k	1.6k	1.3k	750	475	102	5.1k
J. Ashby United Kingdom	37	1.9k 0.8×	2.8k 1.7×	842 0.7×	373 0.5×	1.0k 2.2×	209	5.9k
Joachim G. Liehr United States	40	3.3k 1.4×	1.2k 0.8×	3.1k 2.4×	1.1k 1.5×	259 0.5×	143	7.2k
Shinya Shibutani United States	39	5.0k 2.1×	1.9k 1.2×	1.3k 1.0×	706 0.9×	329 0.7×	111	7.1k
Gregory V. Kryukov United States	36	5.1k 2.2×	1.4k 0.9×	1.7k 1.4×	989 1.3×	406 0.9×	46	9.2k
John S. Bertram United States	36	3.5k 1.5×	1.1k 0.7×	624 0.5×	690 0.9×	315 0.7×	84	6.1k
Alan Hewer United Kingdom	37	2.1k 0.9×	2.6k 1.6×	830 0.7×	754 1.0×	339 0.7×	119	5.4k
Pavel Souček Czechia	41	3.1k 1.3×	1.7k 1.1×	842 0.7×	2.0k 2.6×	229 0.5×	201	6.1k
Mamoun Younes United States	50	3.1k 1.3×	2.0k 1.2×	954 0.7×	2.3k 3.0×	403 0.8×	241	9.3k
Peter Schmezer Germany	42	2.7k 1.2×	2.3k 1.4×	403 0.3×	839 1.1×	560 1.2×	138	5.8k
Eleanor G. Rogan United States	54	4.8k 2.0×	2.4k 1.5×	3.3k 2.6×	1.4k 1.9×	410 0.9×	209	9.8k

Countries citing papers authored by Robert E. Royer

Since Specialization

Citations

This map shows the geographic impact of Robert E. Royer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robert E. Royer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robert E. Royer more than expected).

Fields of papers citing papers by Robert E. Royer

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Robert E. Royer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robert E. Royer. The network helps show where Robert E. Royer may publish in the future.

Co-authorship network of co-authors of Robert E. Royer

This figure shows the co-authorship network connecting the top 25 collaborators of Robert E. Royer. A scholar is included among the top collaborators of Robert E. Royer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Robert E. Royer. Robert E. Royer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Royer, Robert E., et al.. (2016). Profiling Fanconi Anemia Gene Mutations among Iranian Patients.. PubMed. 19(4). 236–40. 9 indexed citations

Orlando, Robert A., Amanda M. Gonzales, Robert E. Royer, Lorraine M. Deck, & David L. Vander Jagt. (2012). A Chemical Analog of Curcumin as an Improved Inhibitor of Amyloid Abeta Oligomerization. PLoS ONE. 7(3). e31869–e31869. 56 indexed citations

Zhang, Shiyu, Robert E. Royer, Song Li, et al.. (2011). Frequencies of BRCA1 and BRCA2 mutations among 1,342 unselected patients with invasive ovarian cancer. Gynecologic Oncology. 121(2). 353–357. 295 indexed citations

Côté, Stéphanie, Suzanna L. Arcand, Robert E. Royer, et al.. (2011). The BRCA2 c.9004G>A (E2003K) variant is likely pathogenic and recurs in breast and/or ovarian cancer families of French Canadian descent. Breast Cancer Research and Treatment. 131(1). 333–340. 12 indexed citations

Le, Anne, Charles R. Cooper, Arvin M. Gouw, et al.. (2010). Inhibition of lactate dehydrogenase A induces oxidative stress and inhibits tumor progression. Proceedings of the National Academy of Sciences. 107(5). 2037–2042. 1169 indexed citations breakdown →

Orlando, Robert A., et al.. (2010). Inhibition of Nuclear Factor κB Activation and Cyclooxygenase-2 Expression by Aqueous Extracts of Hispanic Medicinal Herbs. Journal of Medicinal Food. 13(4). 888–895. 15 indexed citations

Young, S. R., Robert Pilarski, Talia Donenberg, et al.. (2009). The prevalence of BRCA1 mutations among young women with triple-negative breast cancer. BMC Cancer. 9(1). 86–86. 179 indexed citations

Akbari, Mohammad R., Parviz Ghadirian, André Robidoux, et al.. (2008). Germline RAP80 mutations and susceptibility to breast cancer. Breast Cancer Research and Treatment. 113(2). 377–381. 17 indexed citations

Chen, Jixin, Baohua Gu, Robert E. Royer, & William D. Burgos. (2003). The roles of natural organic matter in chemical and microbial reduction of ferric iron. The Science of The Total Environment. 307(1-3). 167–178. 190 indexed citations

10.

Latarjet, R, et al.. (2002). [Quantitative determination of 3, 4-benzopyrene formed by the combustion of cigarette paper and tobacco].. PubMed. 43(2). 180–98. 1 indexed citations

11.

Jagt, David L. Vander, Lorraine M. Deck, & Robert E. Royer. (2000). Gossypol Prototype of Inhibitors Targeted to Dinucleotide Folds. Current Medicinal Chemistry. 7(4). 479–498. 86 indexed citations

12.

Hunsaker, Lucy A., et al.. (1996). Physiological Substrates of Human Aldose and Aldehyde Reductases. Advances in experimental medicine and biology. 414. 491–497. 15 indexed citations

13.

Royer, Robert E.. (1995). Comparison of the antiviral activities of 3′-azido-3′-deoxythymidine (AZT) and gossylic iminolactone (GIL) against clinical isolates of HIV-1. Pharmacological Research. 31(1). 49–52. 22 indexed citations

14.

Royer, Robert E., et al.. (1991). Inhibition of human immunodeficiency virus type I replication by derivatives of gossypol. Pharmacological Research. 24(4). 407–412. 39 indexed citations

15.

Deck, Lorraine M., David L. Vander Jagt, & Robert E. Royer. (1991). Gossypol and derivatives: a new class of aldose reductase inhibitors. Journal of Medicinal Chemistry. 34(11). 3301–3305. 39 indexed citations

16.

Royer, Robert E., et al.. (1986). Biologically active derivatives of gossypol: synthesis and antimalarial activities of peri-acylated gossylic nitriles. Journal of Medicinal Chemistry. 29(9). 1799–1801. 91 indexed citations

17.

Jagt, David L. Vander, et al.. (1985). Isolation and characterization of the multiple glutathione S-transferases from human liver. Evidence for unique heme-binding sites.. Journal of Biological Chemistry. 260(21). 11603–11610. 134 indexed citations

18.

Jagt, David L. Vander, et al.. (1983). Regulation of the glutathione S-transferase activity of bilirubin transport protein (ligandin) from human liver. Enzymic memory involving protein-protein interactions.. Journal of Biological Chemistry. 258(9). 5689–5694. 40 indexed citations

19.

Clark, Charles R., et al.. (1981). Mutagenicity of diesel exhaust particle extracts: Influence of car type. Fundamental and Applied Toxicology. 1(3). 260–265. 25 indexed citations

20.

Brooks, Antone L., et al.. (1981). Deposition and biological availability of diesel particles and their associated mutagenic chemicals. Environment International. 5(4-6). 263–267. 15 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact